Severe hyperkalaemia with nafarelin [21]

Lancet

Volumn 347, Issue 8997, 1996, Pages 333-

  Hata, T ^a   Hata, K ^a   Kawamura, T ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; HYPOTHALAMUS RELEASING FACTOR; NAFARELIN;

ADULT; CASE REPORT; FEMALE; HUMAN; HYPERKALEMIA; INTRANASAL DRUG ADMINISTRATION; LETTER; PRIORITY JOURNAL; UTERUS MYOMA;

EID: 0030031194     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)90514-0     Document Type: Letter

References (3)

1. P. Chrisp Kl Goa Nafarelin A review of its pharmacodynamic and pharmacokinetic properties, and clinical potential in sex hormone-related conditions. Drugs 39 1990 523 551
2. Jl Andreyko Z. Blumenfeld La Marshall Se Monroe H. Hricak Rb Jaffe Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: assessment by magnetic resonance imaging Am J Obstet Gynecol 158 1988 903 910
3. Gd Adamson Treatment of uterine fibroids: Current findings with gonadotropin-releasing hormone agonists Am J Obstet Gynecol 166 1992 746 751